Oncology Devices - Medical Devices Pipeline Assessment, 2016
GlobalData's Medical Devices sector report, “Oncology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Oncology Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Oncology Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
- Extensive coverage of the Oncology Devices under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Oncology Devices and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry
Reasons to buy
- The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Oncology Devices under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product’s current stage of development, territory and estimated launch date
Our reports have been used by over 10K customers, including:
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2018 Summary Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase...
Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Astrocytoma clinical trials scenario.This report provides top line data relating to the clinical...
Venous Thromboembolism Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2018" provides an overview of Venous Thromboembolism clinical trials scenario.This report provides top line data relating to the clinical...
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 22.214.171.124) - Pipeline Review, H2 2018 Summary According to the recently published report ’SerineThreonine Protein Kinase Pim 3 - Pipeline Review, H2 2018’; Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 126.96.36.199)...